Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series-Reference-Cited by-同舟云学术

Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series

Published:2023-04-17 Issue:8 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Licata Gaetano¹^ORCID,Tancredi Vittorio²,Pezzolo Elena³,Pertusi Ginevra⁴,Tolino Ersilia⁵,Arisi Mariachiara⁶^ORCID,Gambardella Alessio²

Affiliation:

1. Dermatology Unit San Antonio Abate Hospital Trapani Italy

2. Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine University of Campania Luigi Vanvitelli Naples Italy

3. Department of Dermatology San Bortolo Hospital Vicenza Italy

4. Department of Dermatology S. Andrea Hospital Vercelli Italy

5. Dermatology Unit “Daniele Innocenzi”, Department of Medical‐Surgical Sciences and Bio‐Technologies Sapienza University of Rome, Fiorini Hospital, Polo Pontino Terracina Italy

6. Dermatology Department, ASST Spedali Civili di Brescia University of Brescia Brescia Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19108

Reference8 articles.

1. Dupilumab for treatment of atopic dermatitis

2. Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib

3. Are serious ophthalmic adverse events on dupilumab treatment for atopic dermatitis dose related?

4. Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis

5. Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life Experience

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of dupilumab‐associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO‐ADOC study);Journal of the European Academy of Dermatology and Venereology;2024-07-17

2. Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical Practice;Journal of Clinical Medicine;2024-06-28

3. Dupilumab/steroids/tacrolimus;Reactions Weekly;2024-04-20

4. Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis;Current Allergy and Asthma Reports;2024-04-18

5. Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients;Australasian Journal of Dermatology;2024-04-08